What Happened
Between May and August, the Department of Justice (DOJ) launched three False Claims Act (FCA) enforcement initiatives targeting federal funding recipients. In May, the Civil Rights Fraud Initiative focused on diversity, equity, and inclusion programs that might violate antidiscrimination laws. In July, the DOJ and the Department of Health and Human Services (HHS) formed a working group to address issues in healthcare and life sciences, encouraging whistleblowers to report Medicare Advantage issues, drug pricing violations, and barriers to patient access. In August, a trade task force began seeking whistleblower complaints against tariff violators.
These initiatives didn't announce specific penalties or defendants. Instead, they highlight enforcement priorities and invite internal sources to file qui tam actions.
Timeline
May: Civil Rights Fraud Initiative targets DEI programs receiving federal funding that allegedly violate antidiscrimination statutes.
July: DOJ-HHS working group focuses on Medicare Advantage billing, drug pricing accuracy, and patient access restrictions.
August: Trade task force solicits whistleblower reports on tariff evasion and customs fraud.
Ongoing: All initiatives align with the administration's mandate to identify waste, fraud, and abuse in federal spending.
Which Controls Failed or Were Missing
These initiatives reveal systemic control deficiencies in organizations handling federal funds:
Missing or inadequate regulatory obligation tracking. Organizations failed to map how their programs interact with federal funding conditions. If you accept Medicare reimbursement, HHS grants, or federal contracts, your obligations library must identify activities that trigger FCA exposure. Many compliance programs track only their primary regulatory framework and miss ancillary statutes like antidiscrimination laws attached to federal dollars.
Weak whistleblower intake and escalation protocols. The DOJ's invitation to internal sources highlights a gap: employees with compliance concerns don't trust internal channels or don't believe leadership will act. If your team learns about potential FCA violations from the DOJ instead of your hotline, your internal reporting structure has failed. This isn't just about having a hotline number on a poster. It's about intake triage, investigation timelines, and credible follow-through that employees can observe.
Inadequate pre-implementation compliance review for new programs. The Civil Rights Fraud Initiative targets programs already in operation. Organizations launched DEI initiatives, pricing structures, or trade practices without vetting them against the full scope of federal funding restrictions. Your compliance control design must include a mandatory review gate before any program that touches federal money goes live. That review needs to answer: which federal statutes apply, what certifications did we make to receive this funding, and what representations are we making to the government about how we'll use it?
What the Relevant Standard Requires
The False Claims Act, 31 U.S.C. §§ 3729-3733, imposes liability for knowingly presenting false claims for payment to the federal government or knowingly making false statements material to a false claim. "Knowingly" includes deliberate ignorance and reckless disregard of the truth.
This creates three compliance obligations:
Accurate certification and representation. When you certify compliance with federal requirements to receive funding, that certification must be accurate at the time you make it and throughout the funding period. If your Medicare Advantage plan certifies accurate risk coding, your billing controls must ensure that accuracy. If you certify compliance with nondiscrimination requirements, your program design must meet those standards.
Reasonable inquiry before certifying. You can't certify compliance without investigating whether it's true. The FCA's "reckless disregard" standard means your compliance team must conduct reasonable due diligence before anyone signs a certification or submits a claim. Document what you checked and what you found.
Prompt disclosure and correction. If you discover you've submitted a false claim or made a false statement, you must disclose it to the government and repay any overpayment. The 60-day repayment rule under the Affordable Care Act (42 U.S.C. § 1320a-7k(d)) requires Medicare and Medicaid providers to report and return overpayments within 60 days of identification. Missing this deadline converts an error into an FCA violation.
For healthcare organizations, the OIG Compliance Program Guidance (published in the Federal Register for various provider types) establishes the baseline: written policies, training, auditing and monitoring, response protocols, and corrective action. These aren't optional. They're the standard of care that courts and prosecutors use to evaluate whether your organization acted reasonably.
Lessons and Action Items for Your Team
Update your regulatory inventory now. Map every source of federal funding your organization receives. For each one, identify the statutes, regulations, and contractual terms that govern how you use that money. Add those obligations to your compliance program scope. If you accept Medicare, Medicaid, research grants, or federal contracts, your obligations library must include the attached compliance certifications.
Test your whistleblower intake against these scenarios. Run a tabletop exercise: an employee reports that your pricing submissions to CMS don't match your actual costs, or that your federal contract work is being performed by ineligible subcontractors, or that your diversity program uses criteria that violate Title VI. Does your intake process escalate these to legal and compliance immediately? Do you have a protocol for investigating potential FCA exposure? Do you have a documented decision tree for when to make a voluntary disclosure? If you're improvising these answers during the exercise, you'll improvise them during a real event.
Build a pre-launch compliance gate for any program touching federal funds. Before you implement a new billing code, launch a new grant-funded program, or change how you classify imports, require a compliance review that asks: what are we certifying to the government, is it accurate, and how will we ensure it stays accurate? Document the review. If you proceed despite identified risks, document why and what mitigating controls you put in place. This documentation is your evidence of reasonable inquiry if DOJ questions your decision later.
Audit your existing certifications. Pull every certification of compliance your organization has made to a federal agency in the past 12 months. For each one, verify it's still accurate. If you certified compliance with antidiscrimination laws, can you demonstrate that compliance today? If you certified accurate risk adjustment coding, have you tested a sample? If you find a false certification, you have 60 days to report and repay. The clock started when you identified it, which is now.
The FCA doesn't require perfection. It requires reasonable systems to prevent false claims and prompt action when you discover them. These initiatives tell you where DOJ is looking and who they're listening to. Use that information to find the gaps before a whistleblower does.
